CD8A and neoplasm: By contrast, in non‐pCR patients, CD8+ T cells in all parts of the post‐NAT tumor (P = 0.005, P = 0.004, P = 0.081) and PD1+CD8+ T cells in the whole tumor area (P = 0.047) increased in comparison with pre‐NAT tumors.